Purdue Pharma can protect Sackler owners in opioid bankruptcy, court rules
Bankrupt OxyContin maker Purdue Pharma can shield its owners, members of the wealthy Sackler family, from opioid lawsuits in exchange for a $6 billion contribution to the company's broader bankruptcy settlement, a U.S. appeals court ruled on Tuesday. The New York-based 2nd U.S. Circuit Court of…
#bankruptoxycontin #purduepharma #purdue #oxycontin #sacklers #2ndcircuit #chapter11
